Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical and Experimental Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16297159PMCID PMC1809533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IFN-α Subtypes Differentially Affect Human T Cell Motility1

  2004cited by this paper
• IFN-α Priming Results in a Gain of Proinflammatory Function by IL-10: Implications for Systemic Lupus Erythematosus Pathogenesis1

  2004cited by this paper
• Herpes Simplex Virus Type-1-Induced Activation of Myeloid Dendritic Cells: The Roles of Virus Cell Interaction and Paracrine Type I IFN Secretion1

  2004cited by this paper
• Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

  2004cited by this paper
• Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

  2004cited by this paper
• Functional repertoire of dendritic cells generated in granulocyte macrophage‐colony stimulating factor and interferon‐α

  2004cited by this paper
• alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.

  2004cited by this paper
• Opposite effects of IFN beta on cytokine homeostasis in LPS- and T cell contact-activated human monocytes.

  2004cited by this paper
• Interleukin-10 Inhibits Interleukin-12 p40 Gene Transcription by Targeting a Late Event in the Activation Pathway

  2004cited by this paper
• Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation 1

  2003cited by this paper
• IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.

  2003cited by this paper
• Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.

  2003cited by this paper
• IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells.

  2003cited by this paper
• Differential responses to IFN-alpha subtypes in human T cells and dendritic cells.

  2003cited by this paper
• Recognition of pathogen-associated molecular patterns by TLR family.

  2003cited by this paper
• Suppression of Interleukin‐12 Production through Endogenously Secreted Interleukin‐10 in Activated Dendritic Cells: Involvement of Activation of Extracellular Signal‐Regulated Protein Kinase

  2003cited by this paper
• CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation

  2003cited by this paper
• Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-gamma-mediated signaling.

  2003cited by this paper
• Hepatitis C virus non‐structural protein 4 suppresses Th1 responses by stimulating IL‐10 production from monocytes

  2003cited by this paper
• IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.

  2002cited by this paper
• The Natural Alliance Between Type I Interferon and Dendritic Cells and Its Role in Linking Innate and Adaptive Immunity

  2002cited by this paper
• Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

  2002cited by this paper
• Two-Photon Imaging of Lymphocyte Motility and Antigen Response in Intact Lymph Node

  2002cited by this paper
• Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production.

  2002cited by this paper
• Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer.

  2001cited by this paper
• Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs1

  2001cited by this paper
• IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1

  2001cited by this paper
• Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression

  2001cited by this paper
• Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.

  2001cited by this paper
• Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?

  2001cited by this paper
• Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells.

  2001cited by this paper
• Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells1

  2001cited by this paper
• Production of IL-12 by Human Monocyte-Derived Dendritic Cells Is Optimal When the Stimulus Is Given at the Onset of Maturation, and Is Further Enhanced by IL-41

  2001cited by this paper
• IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

  2001cited by this paper
• Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice

  2000cited by this paper
• Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors.

  2000cited by this paper
• Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction1

  2000cited by this paper
• Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

  2000cited by this paper
• The human interferon alpha species and receptors.

  2000cited by this paper
• Human T cells elicit IFN-alpha secretion from dendritic cells following cell to cell interactions.

  2000cited by this paper
• Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1.

  1999cited by this paper
• Immunotherapy in renal cell carcinoma.

  1999cited by this paper
• Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.

  1999cited by this paper
• Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells.

  1999cited by this paper
• Retreatment of chronic hepatitis B e antigen–positive patients with recombinant interferon alfa‐2a

  1999cited by this paper
• Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development.

  1998cited by this paper
• CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

  1998cited by this paper
• Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.

  1998cited by this paper
• Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells

  1998cited by this paper
• Type I IFNs enhance the terminal differentiation of dendritic cells.

  1998cited by this paper
• Type I interferons.

  1998cited by this paper
• Are all Type I human interferons equivalent?

  1998cited by this paper
• Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells

  1997cited by this paper
• In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells

  1997cited by this paper
• IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells.

  1997cited by this paper
• Interferon-alpha upregulates both interleukin-10 and interferon-gamma production by human CD4+ T cells.

  1997cited by this paper
• Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells.

  1996cited by this paper
• Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes.

  1996cited by this paper
• High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590]

  1996cited by this paper
• Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors

  1995cited by this paper
• A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses.

  1995cited by this paper
• Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

  1993cited by this paper
• IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.

  1992cited by this paper
• Intermittent interferonemia and interferon responses in multiple sclerosis.

  1991cited by this paper
• The role of interferons in the treatment of hematologic malignancies.

  1988cited by this paper
• Therapy of chronic myelogenous leukemia

  1987cited by this paper
• Multiple Interferon Subtypes: The Phenomenon and Its Relevance

  1987cited by this paper

• Cell- and matrix-based approaches for improvement of islet beta-cell survival and function in vitro and in vivo

  2014cites this paper
• Pretreatment serum interleukin-12 levels in predicting sustained virological response among hepatitis C patients following Pegylated Interferon-α2β plus Ribavirin treatment

  2013cites this paper
• Immunomodulatory effects of interferon-alpha on T cell subsets in Behcet's disease ex vivo, and the in vitro effects of treatment on healthy donor cells

  2012cites this paper
• Interferon-based treatment as adjuvant therapy for hepatitis C virus vaccine candidates against chronic infection

  2011cites this paper
• Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells

  2011cites this paper
• Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab

  2010cites this paper
• Early Interferon-Based Treatment After Detection of Persistent Hepatitis C Virus Infection: A Critical Decision

  2010cites this paper
• Targeted treatment for metastatic renal cell carcinoma and immune regulation.

  2010cites this paper
• Metastatic clear cell carcinoma of the kidney : therapeutic role of bevacizumab

  2010cites this paper
• First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma.

  2008cites this paper
• Tumor-induced suppressor of cytokine signaling 3 inhibits toll-like receptor 3 signaling in dendritic cells via binding to tyrosine kinase 2.

  2008cites this paper
• Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha

  2008cites this paper
• Current approaches in dendritic cell generation and future implications for cancer immunotherapy

  2007cites this paper
• Sendai Virus Infection Induces Efficient Adaptive Immunity Independently of Type I Interferons

  2006cites this paper
• Reduced IFN-alpha secretion by blood dendritic cells in human diabetes.

  2006cites this paper
• Interferon alpha and its contribution to autoimmunity.

  2006cites this paper